• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克拉霉素单独使用以及与头孢曲松联合使用时,均可抑制大环内酯敏感和大环内酯耐药的肺炎链球菌菌株产生肺炎溶血素。

Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.

作者信息

Anderson R, Steel H C, Cockeran R, Smith A M, von Gottberg A, de Gouveia L, Brink A, Klugman K P, Mitchell T J, Feldman C

机构信息

Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South Africa.

出版信息

J Antimicrob Chemother. 2007 Feb;59(2):224-9. doi: 10.1093/jac/dkl479. Epub 2007 Jan 11.

DOI:10.1093/jac/dkl479
PMID:17218449
Abstract

OBJECTIVES

To investigate the effects of clarithromycin (0.01-0.5 mg/L) alone or in combination with ceftriaxone (0.1 and 0.25 mg/L) on pneumolysin production by both macrolide-susceptible and -resistant [2 erm(B) positive and 2 mef(A) positive] strains of Streptococcus pneumoniae.

METHODS

The bacteria were cultured for 6 h at 37 degrees C/5% CO(2) in tryptone soy broth, washed, enumerated and resuspended to 0.5-3 x 10(8) cfu/mL in tissue culture medium, RPMI 1640. After 16 h of incubation at 37 degrees C / 5% CO(2), pneumolysin was assayed in the bacteria-free supernatants, as well as in lysates, using a functional assay based on the influx of calcium into human neutrophils.

RESULTS

Exposure of not only macrolide-susceptible strains, but also the macrolide-resistant strains, of S. pneumoniae to sub-MICs of clarithromycin resulted in dose-related inhibition of the pneumolysin production, whereas production of the toxin was unaffected by ceftriaxone.

CONCLUSIONS

These observations demonstrate that even in the setting of macrolide resistance the production of pneumolysin, a key virulence factor of the pneumococcus, is attenuated by exposure of this microbial pathogen to clarithromycin.

摘要

目的

研究克拉霉素(0.01 - 0.5毫克/升)单独使用或与头孢曲松(0.1和0.25毫克/升)联合使用对大环内酯敏感和耐药的[2株erm(B)阳性和2株mef(A)阳性]肺炎链球菌菌株产生肺炎溶血素的影响。

方法

将细菌在胰蛋白胨大豆肉汤中于37℃/5%二氧化碳条件下培养6小时,洗涤、计数并重悬于组织培养基RPMI 1640中,使其浓度达到0.5 - 3×10⁸ 菌落形成单位/毫升。在37℃/5%二氧化碳条件下孵育16小时后,使用基于钙离子流入人中性粒细胞的功能测定法,对无细菌的上清液以及裂解物中的肺炎溶血素进行检测。

结果

肺炎链球菌的大环内酯敏感菌株和大环内酯耐药菌株暴露于克拉霉素的亚抑菌浓度下,均导致肺炎溶血素产生呈剂量相关的抑制,而毒素的产生不受头孢曲松的影响。

结论

这些观察结果表明,即使在大环内酯耐药的情况下,这种微生物病原体暴露于克拉霉素也会减弱肺炎链球菌关键毒力因子肺炎溶血素的产生。

相似文献

1
Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.克拉霉素单独使用以及与头孢曲松联合使用时,均可抑制大环内酯敏感和大环内酯耐药的肺炎链球菌菌株产生肺炎溶血素。
J Antimicrob Chemother. 2007 Feb;59(2):224-9. doi: 10.1093/jac/dkl479. Epub 2007 Jan 11.
2
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.大环内酯类、阿莫西林、头孢曲松、多西环素、妥布霉素和氟喹诺酮类药物对肺炎链球菌体外产生肺炎溶血素的影响比较。
J Antimicrob Chemother. 2007 Nov;60(5):1155-8. doi: 10.1093/jac/dkm338. Epub 2007 Sep 10.
3
Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.阿奇霉素对大环内酯类敏感和耐药肺炎链球菌的药效学活性,模拟临床可达到的游离血清、上皮衬液和中耳液浓度。
J Antimicrob Chemother. 2003 Jul;52(1):83-8. doi: 10.1093/jac/dkg278. Epub 2003 May 29.
4
Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae.大环内酯类药物对耐大环内酯类肺炎链球菌肺炎溶血素的影响。
Eur Respir J. 2006 May;27(5):1020-5. doi: 10.1183/09031936.06.00116805. Epub 2006 Feb 2.
5
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).在加拿大呼吸道病原体药敏试验(CROSS,1998 - 2004年)的6年期间分离出的肺炎链球菌中的大环内酯类耐药机制。
J Antimicrob Chemother. 2007 Oct;60(4):733-40. doi: 10.1093/jac/dkm273. Epub 2007 Aug 2.
6
Clarithromycin Inhibits Pneumolysin Production via Downregulation of Gene Transcription despite Autolysis Activation.克拉霉素通过下调基因转录抑制肺炎球菌溶血素的产生,尽管自溶激活。
Microbiol Spectr. 2021 Oct 31;9(2):e0031821. doi: 10.1128/Spectrum.00318-21. Epub 2021 Sep 1.
7
Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistance.克拉霉素对表达mef(A)介导耐药的肺炎链球菌的疗效。
Int J Antimicrob Agents. 2004 May;23(5):498-501. doi: 10.1016/j.ijantimicag.2003.09.028.
8
Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.新型 C-4″ 延长芳烷基基团克拉霉素衍生物的合成及抗耐大环内酯菌株的抗菌活性评价。
Eur J Med Chem. 2011 Feb;46(2):556-66. doi: 10.1016/j.ejmech.2010.11.035. Epub 2010 Nov 27.
9
Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation.阿奇霉素静脉给药预测上皮衬液与血清中肺炎链球菌杀伤作用的药效学参数:一项体外药效学模拟研究
J Antimicrob Chemother. 2006 Jun;57(6):1128-33. doi: 10.1093/jac/dkl140. Epub 2006 Apr 14.
10
Clarithromycin mediated the expression of polymorphonuclear granulocyte response against streptococcus pneumoniae strains with different patterns of susceptibility and resistance to penicillin and clarithromycin.克拉霉素介导了多形核粒细胞对不同青霉素和克拉霉素敏感及耐药模式的肺炎链球菌菌株的反应表达。
Int J Tissue React. 2002;24(1):37-44.

引用本文的文献

1
Analyzing atomic scale structural details and nuclear spin dynamics of four macrolide antibiotics: erythromycin, clarithromycin, azithromycin, and roxithromycin.分析四种大环内酯类抗生素:红霉素、克拉霉素、阿奇霉素和罗红霉素的原子尺度结构细节和核自旋动力学。
RSC Adv. 2024 Jun 3;14(25):17733-17770. doi: 10.1039/d4ra00718b. eCollection 2024 May 28.
2
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy.成人社区获得性肺炎全球负担,包括侵袭性肺炎球菌病和其相关心血管事件的患病率,重点关注肺炎球菌溶血素和大环内酯类抗生素在发病机制和治疗中的作用。
Int J Mol Sci. 2023 Jul 3;24(13):11038. doi: 10.3390/ijms241311038.
3
Chitosan loaded RNA polymerase inhibitor nanoparticles increased attenuation in toxin release from .负载壳聚糖的RNA聚合酶抑制剂纳米颗粒增加了……毒素释放的衰减。 (原句似乎不完整,“from”后面缺少具体内容)
Saudi Pharm J. 2023 Jan;31(1):170-179. doi: 10.1016/j.jsps.2022.11.015. Epub 2022 Nov 25.
4
Matcha Green Tea Exhibits Bactericidal Activity against and Inhibits Functional Pneumolysin.抹茶绿茶对[具体对象未给出]具有杀菌活性并抑制功能性肺炎溶血素。
Antibiotics (Basel). 2021 Dec 17;10(12):1550. doi: 10.3390/antibiotics10121550.
5
Clarithromycin Inhibits Pneumolysin Production via Downregulation of Gene Transcription despite Autolysis Activation.克拉霉素通过下调基因转录抑制肺炎球菌溶血素的产生,尽管自溶激活。
Microbiol Spectr. 2021 Oct 31;9(2):e0031821. doi: 10.1128/Spectrum.00318-21. Epub 2021 Sep 1.
6
Discovery of Antibacterials That Inhibit Bacterial RNA Polymerase Interactions with Sigma Factors.发现抑制细菌 RNA 聚合酶与 sigma 因子相互作用的抗菌药物。
J Med Chem. 2020 Jul 23;63(14):7695-7720. doi: 10.1021/acs.jmedchem.0c00520. Epub 2020 Jul 7.
7
Cigarette smoke exposure induces expression of the pneumococcal erm(B) macrolide resistance gene.接触香烟烟雾会诱导肺炎链球菌erm(B)大环内酯抗性基因的表达。
Tob Induc Dis. 2019 Nov 19;17:82. doi: 10.18332/tid/113528. eCollection 2019.
8
First-In-Class Inhibitors Targeting the Interaction between Bacterial RNA Polymerase and Sigma Initiation Factor Affect the Viability and Toxin Release of .靶向细菌 RNA 聚合酶与 Sigma 起始因子相互作用的首创抑制剂影响 的活力和毒素释放。
Molecules. 2019 Aug 9;24(16):2902. doi: 10.3390/molecules24162902.
9
In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections.克拉霉素和阿奇霉素的体外活性及药效学/药代动力学参数:它们在呼吸道感染治疗中为何重要。
Infect Drug Resist. 2019 Mar 8;12:585-596. doi: 10.2147/IDR.S187226. eCollection 2019.
10
Challenges in severe community-acquired pneumonia: a point-of-view review.严重社区获得性肺炎的挑战:观点综述。
Intensive Care Med. 2019 Feb;45(2):159-171. doi: 10.1007/s00134-019-05519-y. Epub 2019 Jan 31.